Akt2 cKO promotes upregulation of Akt1 and prevents the diabetes-induced increased protein levels of ICAM-1 and iNOS in the RPE by mediating the GSK3β/NF-κB signaling pathway. Here, NFKB1 is linked to diabetes mellitus.